2.8.1 Parenteral anticoagulants
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Venous thromboembolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Venous thromboembolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Venous thromboembolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Venous thromboembolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Venous thromboembolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Venous thromboembolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary arterial hypertension |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
| Cardiovascular system | Acute coronary syndrome |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Pulmonary embolism |
On formulary for the treatment of:
| Therapeutic Area | Condition |
|---|---|
| Cardiovascular system | Venous thromboembolism |
| Cardiovascular system | Pulmonary embolism |